Otis Worldwide Corporation Peer Comparison
Metric | Value | Ranking | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $38.4 Billion | 5/12 | ETN $122.5B |
PH $87.4B |
ITW $75.6B |
EMR $70.2B |
OTIS $38.4B |
IR $36.8B |
DOV $27.6B |
PNR $16.2B |
IEX $14.7B |
GGG $14.4B |
AOS $9.5B |
FLS $8.1B |
Gross Margin | 100% | 1/12 | OTIS 100% |
EMR 100% |
GGG 51% |
ITW 44% |
IR 44% |
IEX 44% |
ETN 40% |
DOV 39% |
PNR 39% |
PH 37% |
AOS 37% |
FLS 32% |
Profit Margin | 9% | 11/12 | DOV 74% |
ITW 29% |
GGG 20% |
PNR 17% |
ETN 16% |
IEX 15% |
EMR 14% |
PH 14% |
IR 12% |
AOS 12% |
OTIS 9% |
FLS 5% |
EBITDA margin | 14% | 10/12 | ITW 39% |
GGG 24% |
IEX 21% |
PNR 20% |
ETN 19% |
IR 19% |
PH 18% |
AOS 17% |
DOV 15% |
OTIS 14% |
EMR 14% |
FLS 11% |
Quarterly Revenue | $3.7 Billion | 5/12 | ETN $6.3B |
PH $4.9B |
EMR $4.2B |
ITW $4.0B |
OTIS $3.7B |
DOV $1.9B |
IR $1.9B |
FLS $1.1B |
PNR $972.9M |
AOS $912.4M |
IEX $798.2M |
GGG $548.7M |
Quarterly Earnings | $337.0 Million | 6/12 | DOV $1.4B |
ITW $1.2B |
ETN $1.0B |
PH $698.4M |
EMR $593.0M |
OTIS $337.0M |
IR $221.6M |
PNR $166.4M |
IEX $119.1M |
AOS $109.7M |
GGG $108.7M |
FLS $58.4M |
Quarterly Free Cash Flow | $651.0 Million | 4/12 | ETN $1.7B |
ITW $783.0M |
EMR $694.0M |
OTIS $651.0M |
PH $648.7M |
IR $433.7M |
IEX $191.6M |
FLS $154.6M |
DOV -$0 |
PNR -$0 |
AOS -$0 |
GGG -$0 |
Trailing 4 Quarters Revenue | $14.3 Billion | 5/12 | ETN $24.6B |
PH $20.0B |
EMR $17.6B |
ITW $15.9B |
OTIS $14.3B |
DOV $8.2B |
IR $7.2B |
FLS $4.5B |
PNR $4.1B |
AOS $3.8B |
IEX $3.2B |
GGG $2.1B |
Trailing 4 Quarters Earnings | $1.6 Billion | 6/12 | ETN $6.3B |
PH $4.9B |
EMR $4.2B |
ITW $4.0B |
OTIS $3.7B |
DOV $1.9B |
IR $1.9B |
FLS $1.1B |
PNR $972.9M |
AOS $912.4M |
IEX $798.2M |
GGG $548.7M |
Quarterly Earnings Growth | 4% | 8/12 | DOV 385% |
EMR 349% |
ITW 50% |
FLS 26% |
ETN 13% |
PH 7% |
IR 6% |
OTIS 4% |
GGG -1% |
PNR -20% |
AOS -20% |
IEX -43% |
Annual Earnings Growth | 13% | 5/12 | DOV 131% |
FLS 34% |
ETN 21% |
ITW 14% |
OTIS 13% |
IR 12% |
PH 4% |
PNR 3% |
EMR 2% |
AOS -2% |
GGG -5% |
IEX -22% |
Quarterly Revenue Growth | 2% | 4/12 | ETN 8% |
IR 7% |
FLS 4% |
OTIS 2% |
EMR 1% |
PH 1% |
IEX 1% |
PNR -1% |
ITW -2% |
GGG -3% |
DOV -8% |
AOS -8% |
Annual Revenue Growth | 1% | 6/12 | EMR 7% |
ETN 5% |
IR 5% |
FLS 5% |
PNR 2% |
OTIS 1% |
AOS 0% |
PH -1% |
ITW -2% |
GGG -3% |
DOV -4% |
IEX -4% |
Cash On Hand | $2.3 Billion | 2/12 | EMR $2.8B |
OTIS $2.3B |
DOV $1.8B |
IR $1.4B |
ITW $947.0M |
GGG $675.3M |
IEX $633.2M |
FLS $611.7M |
ETN $473.0M |
PH $371.1M |
AOS $239.6M |
PNR $118.7M |
Short Term Debt | $1.4 Billion | 3/12 | PH $3.5B |
ITW $1.8B |
OTIS $1.4B |
EMR $1.1B |
ETN $717.0M |
DOV $400.1M |
FLS $66.9M |
GGG $28.5M |
AOS $10.0M |
PNR $9.3M |
IR $2.9M |
IEX $600,000 |
Long Term Debt | $7.3 Billion | 2/12 | ETN $9.4B |
OTIS $7.3B |
PH $6.7B |
ITW $6.6B |
EMR $6.6B |
IR $4.8B |
DOV $2.5B |
IEX $2.1B |
PNR $1.6B |
FLS $1.2B |
AOS $206.7M |
GGG $12.3M |
PE | 23.32 | 9/12 | IR 43.90 |
ETN 32.49 |
FLS 30.41 |
PH 30.21 |
IEX 29.88 |
GGG 29.57 |
EMR 29.02 |
PNR 25.89 |
OTIS 23.32 |
ITW 21.88 |
AOS 17.73 |
DOV 10.23 |
PS | 2.69 | 10/12 | GGG 6.80 |
IR 5.14 |
ETN 4.98 |
ITW 4.74 |
IEX 4.59 |
PH 4.37 |
EMR 4.00 |
PNR 3.97 |
DOV 3.37 |
OTIS 2.69 |
AOS 2.48 |
FLS 1.79 |
PB | 0.00 | 12/12 | ITW 22.29 |
ETN 6.39 |
PH 5.60 |
GGG 5.56 |
PNR 4.54 |
AOS 4.43 |
DOV 3.97 |
FLS 3.87 |
IEX 3.84 |
IR 3.56 |
EMR 1.91 |
OTIS 0.00 |
PC | 16.68 | 10/12 | ETN 258.91 |
PH 235.42 |
PNR 136.40 |
ITW 79.84 |
AOS 39.49 |
IR 26.74 |
EMR 24.77 |
IEX 23.15 |
GGG 21.28 |
OTIS 16.68 |
DOV 14.95 |
FLS 13.31 |
Liabilities to Equity | 0.00 | 12/12 | ITW 3.67 |
FLS 1.54 |
ETN 1.05 |
PH 0.90 |
IEX 0.82 |
PNR 0.81 |
DOV 0.80 |
IR 0.77 |
AOS 0.52 |
EMR 0.22 |
GGG 0.21 |
OTIS 0.00 |
ROA | 0.15 | 4/12 | DOV 22% | ITW 22% | AOS 16% | OTIS 15% | GGG 15% | ETN 10% | PNR 10% | PH 10% | IEX 7% | EMR 6% | IR 5% | FLS 5% |
ROE | -0.34 | 12/12 | ITW 102% |
DOV 39% |
AOS 25% |
ETN 20% |
PH 19% |
GGG 19% |
PNR 18% |
IEX 13% |
FLS 13% |
EMR 9% |
IR 8% |
OTIS -34% |
Current Ratio | 0.71 | 12/12 | EMR 7.24 |
GGG 5.66 |
AOS 2.94 |
IR 2.31 |
DOV 2.25 |
PNR 2.24 |
IEX 2.21 |
PH 2.11 |
ETN 1.95 |
FLS 1.66 |
ITW 1.27 |
OTIS 0.71 |
Quick Ratio | 0.14 | 8/12 | IR 43.90 |
ETN 32.49 |
FLS 30.41 |
PH 30.21 |
IEX 29.88 |
GGG 29.57 |
EMR 29.02 |
PNR 25.89 |
OTIS 23.32 |
ITW 21.88 |
AOS 17.73 |
DOV 10.23 |
Long Term Debt to Equity | -1.50 | 12/12 | ITW} 1.94 |
FLS} 0.57 |
IEX} 0.54 |
ETN} 0.49 |
IR} 0.47 |
PNR} 0.46 |
PH} 0.43 |
DOV} 0.36 |
EMR} 0.25 |
AOS} 0.10 |
GGG} 0.00 |
OTIS} -1.50 |
Debt to Equity | -1.78 | 12/12 | ITW 2.46 |
PH 0.65 |
FLS 0.60 |
IEX 0.54 |
ETN 0.53 |
IR 0.47 |
PNR 0.46 |
DOV 0.42 |
EMR 0.29 |
AOS 0.10 |
GGG 0.02 |
OTIS -1.78 |
Burn Rate | 7.89 | 2/12 | FLS 116.33 |
OTIS 7.89 |
PH 0.83 |
ETN -1.04 |
PNR -1.20 |
DOV -1.49 |
ITW -2.08 |
AOS -2.42 |
GGG -6.68 |
IEX -17.62 |
EMR -44.13 |
IR -46.56 |
Cash to Cap | 0.06 | 3/12 | FLS 0.08 |
DOV 0.07 |
OTIS 0.06 |
GGG 0.05 |
EMR 0.04 |
IR 0.04 |
IEX 0.04 |
AOS 0.03 |
ITW 0.01 |
PNR 0.01 |
ETN 0.00 |
PH 0.00 |
CCR | 1.93 | 3/12 | FLS 2.65 |
IR 1.96 |
OTIS 1.93 |
ETN 1.66 |
IEX 1.61 |
EMR 1.17 |
PH 0.93 |
ITW 0.68 |
DOV |
PNR |
AOS |
GGG |
EV to EBITDA | 84.15 | 9/12 | EMR} 126.47 |
IR} 112.89 |
PH} 111.03 |
ETN} 109.87 |
GGG} 105.67 |
DOV} 97.16 |
IEX} 95.82 |
PNR} 90.83 |
OTIS} 84.15 |
FLS} 73.33 |
AOS} 60.46 |
ITW} 54.08 |
EV to Revenue | 3.13 | 10/12 | GGG 6.50 |
IR 5.62 |
ETN 5.37 |
ITW 5.20 |
IEX 5.04 |
PH 4.86 |
PNR 4.34 |
EMR 4.27 |
DOV 3.50 |
OTIS 3.13 |
AOS 2.47 |
FLS 1.93 |